Cargando…

STAT3 Inhibitors: A Novel Insight for Anticancer Therapy of Pancreatic Cancer

The signal transducer and activator of transcription (STAT) is a family of intracellular cytoplasmic transcription factors involved in many biological functions in mammalian signal transduction. Among them, STAT3 is involved in cell proliferation, differentiation, apoptosis, and inflammatory respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xin, Jiang, Wenkai, Dong, Shi, Li, Wancheng, Zhu, Weixiong, Zhou, Wence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599947/ https://www.ncbi.nlm.nih.gov/pubmed/36291659 http://dx.doi.org/10.3390/biom12101450

Ejemplares similares

Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer
por: LI, XIN, et al.
Publicado: (2023)

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer
por: Li, Xin, et al.
Publicado: (2023)

Current understanding of ferroptosis in the progression and treatment of pancreatic cancer
por: Dong, Shi, et al.
Publicado: (2021)

New challenges for microRNAs in acute pancreatitis: progress and treatment
por: Zhou, Wence, et al.
Publicado: (2022)

Neutrophils in pancreatic cancer: Potential therapeutic targets
por: Jiang, Wenkai, et al.
Publicado: (2022)

Efficacy of Glutamine in Treating Severe Acute Pancreatitis: A Systematic Review and Meta-Analysis
por: Dong, Shi, et al.
Publicado: (2022)

Immunocyte Infiltration Analysis and Immunohistochemistry Identify EVL as a Potential Prognostic Biomarker for Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis
por: Shi, Huaqing, et al.
Publicado: (2023)

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
por: Dong, Shi, et al.
Publicado: (2022)

Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis
por: Du, Yan, et al.
Publicado: (2023)

A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2023)

Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
por: Zhou, Wence, et al.
Publicado: (2022)

The Global, Regional and National Burden of Pancreatic Cancer Attributable to Smoking, 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019
por: Jiang, Wenkai, et al.
Publicado: (2023)

Age-period-cohort analysis of pancreatitis epidemiological trends from 1990 to 2019 and forecasts for 2044: a systematic analysis from the Global Burden of Disease Study 2019
por: Jiang, Wenkai, et al.
Publicado: (2023)

Time trend of pancreatic cancer mortality in the Western Pacific Region: age-period-cohort analysis from 1990 to 2019 and forecasting for 2044
por: Jiang, Wenkai, et al.
Publicado: (2023)

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
por: Wang, Zhengfeng, et al.
Publicado: (2023)

Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer
por: Jiang, Wenkai, et al.
Publicado: (2022)

Identification of marine natural product Pretrichodermamide B as a STAT3 inhibitor for efficient anticancer therapy
por: Li, Rui, et al.
Publicado: (2023)

Understanding Necroptosis in Pancreatic Diseases
por: He, Ru, et al.
Publicado: (2022)

Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations
por: Chen, Zhou, et al.
Publicado: (2022)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

Mistletoe and Immunomodulation: Insights and Implications for Anticancer Therapies
por: Oei, Shiao Li, et al.
Publicado: (2019)

A novel proteasome inhibitor NPI-0052 as an anticancer therapy
por: Chauhan, D, et al.
Publicado: (2006)

Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer)
por: Sikander, Mohammed, et al.
Publicado: (2019)

Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: Novel insights and perspectives
por: Wang, Haiying, et al.
Publicado: (2023)

STAT inhibitors for cancer therapy
por: Furqan, Muhammad, et al.
Publicado: (2013)

Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
por: Sgrignani, Jacopo, et al.
Publicado: (2018)

The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy
por: Tolomeo, Manlio, et al.
Publicado: (2021)

Integrated bioinformatics analysis of potential biomarkers for pancreatic cancer
por: Shi, Huaqing, et al.
Publicado: (2022)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3/STAT5a inhibitors
por: Lamie, Phoebe F., et al.
Publicado: (2020)

Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapy
por: Si, Yishimei, et al.
Publicado: (2022)

Cardiac Glycoside Ouabain Exerts Anticancer Activity via Downregulation of STAT3
por: Du, Jie, et al.
Publicado: (2021)

Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
por: Hua, Yaping, et al.
Publicado: (2022)

A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study
por: Shi, Huaqing, et al.
Publicado: (2022)

Inhibition of STAT3 by Anticancer Drug Bendamustine
por: Iwamoto, Kazunori, et al.
Publicado: (2017)

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015)

Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor
por: Cheng, Xin, et al.
Publicado: (2016)

LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ive7rpjo81djqo62t106lks3kd